Global automated autoinjectors market expected to generate around USD 18.19 billion by 2025, at a CAGR of around 21.7% between 2019 and 2025. Automated autoinjectors are needle-based medical devices used for the administration of fixed dose for specific drug doses.
Sarasota, FL -- (SBWIRE) -- 02/26/2019 -- Zion Market Research has published a new report titled "Automated Autoinjectors Market by Design (Customized Autoinjector and Standardized Autoinjector), by Usage (Reusable Autoinjector and Disposable Autoinjector), by Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, and Others), and by End-User (Hospitals & Clinics and Home Care Settings): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025". According to the report, the global automated autoinjectors market was valued at approximately USD 4.6 billion in 2018 and is expected to generate around USD 18.19 billion by 2025, at a CAGR of around 21.7% between 2019 and 2025.
Download Free PDF Research Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/automated-autoinjectors-market
Automated autoinjectors are needle-based medical devices used for the administration of fixed dose for specific drug doses. It is used for self-administration by untrained personnel or patients, as it is easy to handle. Furthermore, these devices are used for various allergic reactions, such as wheezing, trouble in breathing, stomach pain, nausea, dizziness, swelling on face, lips, mouth, and tongue and skin allergies, like hives, itching, flushing, etc. Furthermore, the administration site depends on the nature of the drug. For example, insulin shots are injected in the abdomen for quick action. Automated autoinjectors are easy to use and have various advantages, such as reduced needle phobia anxiety, lowered chances of needlestick injuries, better efficacy, and consistent dose accuracy, which, in turn, are likely to propel the automated autoinjectors market globally in the future.
The automated autoinjectors market is divided on the basis of design, application, usage, and end-user. By design, the automated autoinjectors market is includes customized autoinjector and standardized autoinjector. Customized autoinjectors held the largest market share in 2018 in terms of revenue. The standardized autoinjectors are likely to grow rapidly in the future.
By usage, the market is segmented into reusable autoinjector and disposable autoinjector. Reusable autoinjectors held the largest market share in 2018 in terms of revenue, due to their cost-effectiveness and multi-use nature. Furthermore, disposable autoinjectors are intended for better handling and are more popular along with offering enhanced safety features, making it them a preferable option. Thus, this segment is likely to register a high CAGR over the forecast timeline.
The application segment includes anaphylaxis, rheumatoid arthritis, multiple sclerosis, diabetes, and others. Rheumatoid arthritis held a significant share in the market in 2018, owing to the rising prevalence of rheumatoid arthritis (RA). According to Sanofi, more than 400,000 people in the UK suffered from RA in 2017. This number is likely to increase further in the upcoming years.
By end-user, the market is segmented into hospitals and clinics and home care settings. Home care settings held a major market share of the market in 2018, due to the ease in monitoring and operation of these devices to deliver early emergency care at affordable rates, as these are designed with a user-centric approach in reducing user-associated risk.
By region, North America dominated the global automated autoinjectors market in 2018. Presence of several leading players and favorable reimbursement scenario are major factors likely to propel the North American automated autoinjectors market in the future. The Asia Pacific automated autoinjectors market is projected to witness rapid growth in the next few years, owing to the rising awareness among consumers regarding the advanced treatment methods that are available. Lucrative growth opportunities in Japan, India, and China and technological advancements, increased healthcare expenditure, mandatory healthcare insurance, and the rising number of global companies catering to the unmet medical needs of the regional population are likely to further propel the automated autoinjectors market growth in this region.
Request Free Sample Report @ https://www.zionmarketresearch.com/sample/automated-autoinjectors-market
Some leading players of the global automated autoinjectors market include Unilife Corporation, Becton, Dickinson & Co., Biogen Idec, Pfizer, Inc., Mylan N.V., Sanofi, Owen Mumford, Teva Pharmaceutical, Amgen, Ypsomed, AbbVie, and Scandinavian Health Ltd.
This report segments the global automated autoinjectors market into:
Global Automated Autoinjectors Market: Design Analysis
Global Automated Autoinjectors Market: Usage Analysis
Global Automated Autoinjectors Market: Application Analysis
Global Automated Autoinjectors Market: End-User Analysis
Hospitals and Clinics
Home Care Settings
Inquiry more about this report @ https://www.zionmarketresearch.com/inquiry/automated-autoinjectors-market
Global Automated Autoinjectors Market: Regional Analysis
The Middle East and Africa